Literature DB >> 15794839

Frontobasal interhemispheric trans-lamina terminalis approach for suprasellar lesions.

Amir R Dehdashti1, Nicolas de Tribolet.   

Abstract

The frontobasal interhemispheric approach for suprasellar tumors currently incorporates technological advancements and refinements in patient selection, operative technique, and postoperative care. This technique is a valid choice for the removal of suprasellar lesions with extension into the third ventricle without major sequelae related to the surgical approach. The method described here reflects the combination of the frontal interhemispheric and trans-lamina terminalis approaches.

Entities:  

Mesh:

Year:  2005        PMID: 15794839     DOI: 10.1227/01.neu.0000157027.80293.c7

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  4 in total

1.  Olfactory preservation during anterior interhemispheric approach for anterior skull base lesions: technical note.

Authors:  Fumihiro Matano; Yasuo Murai; Takayuki Mizunari; Kojiro Tateyama; Shiro Kobayashi; Koji Adachi; Hiroyasu Kamiyama; Akio Morita; Akira Teramoto
Journal:  Neurosurg Rev       Date:  2015-07-17       Impact factor: 3.042

2.  Anterior callosal section is useful for the removal of large tumors invading the dorsal part of the anterior third ventricle: operative technique and results.

Authors:  Hideki Shiramizu; Tomokatsu Hori; Seigo Matsuo; Kaku Niimura; Haruko Yoshimoto; Atsushi Ishida; Keizoh Asakuno; Miki Yuzawa; Takashi Moriyama
Journal:  Neurosurg Rev       Date:  2013-04-09       Impact factor: 3.042

3.  Extended endoscopic endonasal transsphenoidal approach for retrochiasmatic craniopharyngioma: Surgical technique and results.

Authors:  Suresh K Sankhla; Narayan Jayashankar; Ghulam M Khan
Journal:  J Pediatr Neurosci       Date:  2015 Oct-Dec

4.  The interhemispheric fissure-surgical outcome of interhemispheric approaches.

Authors:  A Kaywan Aftahy; Melanie Barz; Arthur Wagner; Friederike Liesche-Starnecker; Chiara Negwer; Bernhard Meyer; Jens Gempt
Journal:  Neurosurg Rev       Date:  2020-08-27       Impact factor: 3.042

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.